GlassScriptPhysician profile
Tyler John Bonkowski
NPI 1174185904
$11,669.82
in general payments reported to CMS, 2019-2025
28 companies · $2,792 in 2025
The $2,792 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $539 · 2022: $925 · 2023: $4,814 · 2024: $2,601 · 2025: $2,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,264 · Travel and Lodging: $2,601 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,550 · Long Term Medical Supply Or Device Loan: $429 · Education: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,264.04 |
| Travel and Lodging | $2,601.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,550.00 |
| Long Term Medical Supply Or Device Loan | $429.00 |
| Education | $361.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eko Health, INC. | $2,728.00 | 2021-2024 | |
| Abbott Laboratories | $2,423.95 | 2023-2025 | Cardiomems, Coroflow, Ensite |
| Zoll Circulation INC | $1,772.31 | 2022-2023 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Astrazeneca Pharmaceuticals LP | $918.32 | 2022-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $812.90 | 2022-2025 | Lifevest |
| Cardiva Medical, INC. | $398.05 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Boston Scientific Corporation | $329.97 | 2023-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, Rotapro |
| Amgen INC. | $309.25 | 2022-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $252.65 | 2024-2025 | |
| Endotronix, INC. | $222.81 | 2025 | Cordella Pulomonary Artery Pressure Sensor, Cordella Pulmonary Artery Pressure Sensor |
| Shockwave Medical, INC | $222.01 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $158.13 | 2023-2024 | Impella |
| Lantheus Medical Imaging, INC. | $152.80 | 2022-2023 | Definity |
| Stryker Corporation | $145.83 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.84 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $106.47 | 2025 | Assure Wcd |
| Novo Nordisk INC | $88.20 | 2024 | Wegovy |
| Bridgebio Pharma, INC. | $82.09 | 2025 | Attruby |
| Pfizer INC. | $70.48 | 2022-2025 | |
| Inari Medical, INC. | $54.34 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Chiesi USA, INC. | $53.43 | 2024 | Kengreal |
| Medtronic, INC. | $51.70 | 2022 | |
| Terumo Medical Corporation | $49.97 | 2023 | Angio-Seal, Tr Band |
| Novartis Pharmaceuticals Corporation | $40.84 | 2024 | |
| Haemonetics Corporation | $36.24 | 2025 | Teg6s Hemostasis System |
| Teleflex LLC | $35.67 | 2023-2025 | Turnpike, Manta |
| Otsuka America Pharmaceutical, INC. | $15.76 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Bonkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.